Novo Holdings Viridian Therapeutics, Inc.\De Transaction History
Novo Holdings
- $1.11 Billion
- Q1 2025
A detailed history of Novo Holdings transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Novo Holdings holds 2,250,300 shares of VRDN stock, worth $32.8 Million. This represents 2.73% of its overall portfolio holdings.
Number of Shares
2,250,300
Previous 2,250,000
0.01%
Holding current value
$32.8 Million
Previous $43.1 Million
29.67%
% of portfolio
2.73%
Previous 3.5%
Shares
5 transactions
Others Institutions Holding VRDN
# of Institutions
189Shares Held
79.6MCall Options Held
92.2KPut Options Held
55.2K-
Deep Track Capital, LP Greenwich, CT5.38MShares$78.4 Million2.54% of portfolio
-
Black Rock Inc. New York, NY4.77MShares$69.6 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ4.7MShares$68.5 Million5.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.56MShares$66.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3.88MShares$56.6 Million12.64% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $581M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...